Brainstorm Cell Therapeutics (BCLI) Insider Trading & Ownership $0.26 0.00 (-1.43%) (As of 05:18 PM ET) Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Brainstorm Cell Therapeutics (NASDAQ:BCLI) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage5.45%Number OfInsiders Buying(Last 12 Months)0Number OfInsiders Selling(Last 12 Months)1Amount OfInsider Selling(Last 12 Months)$22,050.00 Get BCLI Insider Trade Alerts Want to know when executives and insiders are buying or selling Brainstorm Cell Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address BCLI Insider Buying and Selling by Quarter Ad Porter & CompanyI’m giving you the name of this investment for freeIn this video I reveal one of the most powerful wealth secrets in American history. One that has been buried in America’s legal system for the last 150 years. But I believe this secret could also help you reclaim your dignity and freedom before it’s all taken away from you. Watch now. Brainstorm Cell Therapeutics Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame Start Date End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails7/19/2024Ibrahim B. DagherInsiderSell63,000$0.35$22,050.00 (Data available from 1/1/2013 forward) BCLI Insider Trading Activity - Frequently Asked Questions Who is on Brainstorm Cell Therapeutics's Insider Roster? The list of insiders at Brainstorm Cell Therapeutics includes Ibrahim B. Dagher, and Stacy Lindborg. Learn more on insiders at BCLI. What percentage of Brainstorm Cell Therapeutics stock is owned by insiders? 5.45% of Brainstorm Cell Therapeutics stock is owned by insiders. Learn more on BCLI's insider holdings. Which Brainstorm Cell Therapeutics insiders have been buying company stock? The following insider purchased BCLI shares in the last 24 months: Stacy Lindborg ($20,355.00). How much insider buying is happening at Brainstorm Cell Therapeutics? Insiders have purchased a total of 11,500 BCLI shares in the last 24 months for a total of $20,355.00 bought. Which Brainstorm Cell Therapeutics insiders have been selling company stock? The following insider sold BCLI shares in the last 24 months: Ibrahim B. Dagher ($22,050.00). How much insider selling is happening at Brainstorm Cell Therapeutics? Insiders have sold a total of 63,000 Brainstorm Cell Therapeutics shares in the last 24 months for a total of $22,050.00 sold. More Insider Trading Tools from MarketBeat Related Companies: CSBR Insider Trading RLMD Insider Trading CLSD Insider Trading CDTX Insider Trading ACRS Insider Trading VRCA Insider Trading IKNA Insider Trading MIST Insider Trading OVID Insider Trading CMRX Insider Trading Insider Tracking Tools: CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country: U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles: Matador Resources Insiders Keep Buying Its Stock, Should You?Top 3 Small-Cap Stocks Insiders Are Buying Right Now3 Small Cap Stocks That Insiders Are BuyingMGM Insiders Bet Big on Its Undervalued Stock3 Small Cap Stocks Insiders Are Actively Buying This page (NASDAQ:BCLI) was last updated on 9/17/2024 by MarketBeat.com Staff From Our PartnersElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredProtect Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | Sponsored⭕ [URGENT] Buy Alert just triggeredMy absolute favorite stock just hit a critical "buy now" trigger price.Behind the Markets | SponsoredSell NVDA Now?Guess who's selling NVDA next The most successful hedge fund in history quietly sold 500,000 shares. Here's...Chaikin Analytics | SponsoredHow Boeing Disasters Could Impact NvidiaHow The Boeing Disasters Could Hit Nvidia Investors You may have heard about Boeing planes falling apart mi...Stansberry Research | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredTrillion Dollar Blockchain Shift Could Trigger THIS CoinIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredMan who Predicted Trump 2016 Win: “Prepare for Election Meltdown”Former advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… ...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Brainstorm Cell Therapeutics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Brainstorm Cell Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.